ImmunityBioNASDAQ: IBRX: Develops next-generation immunotherapies for cancer and infectious diseases.
1+ YOEExperience in molecular cloning, viral vector construction, human tissue culture, upstream bioprocessing, BSL-2 lab work, assay development, data analysis, technical writing, and supporting tech transfer to cGMP manufacturing.
Microsoft Word, Microsoft Excel, Microsoft Visio, JMP